Steven Feldman to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Steven Feldman has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.488
-
Ramachandran V, Bertus B, Bashyam AM, Feldman SR. Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2020 09; 54(9):872-878.
Score: 0.177
-
Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
Score: 0.161
-
Howell ST, Cardwell LA, Feldman SR. Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials. Ann Pharmacother. 2018 04; 52(4):380-387.
Score: 0.151